AI English summary of an SEC filing — figures as filed
Ventas said it entered into Amendment No. 1 to its ATM Sales Agreement on June 13, 2025, September 18, 2024, with BofA Securities, Inc. and other sales agents and forward sellers, and with forward purchasers.
Key points
AI summaryVentas said it entered into Amendment No. 1 to its ATM Sales Agreement on June 13, 2025, September 18, 2024, with BofA Securities, Inc. and other sales agents and forward sellers, and with forward purchasers.
The company said that under Amendment No. 1, the aggregate gross sales price of common stock now available for issuance under the Sales Agreement is $2,250,000,000, and that this amount excludes shares sold under the Sales Agreement before Amendment No. 1 was executed.
The company said shares it issues and sells under the Sales Agreement, and shares borrowed by forward purchasers and sold, will be offered under Form S-3 (File No. 333-277185) and the prospectus supplement filed the same day.
The company said it is filing Amendment No. 1 as Exhibit 1.1 and a Davis Polk & Wardwell LLP opinion on the validity of common stock as Exhibit 5.1, and incorporating both into the registration statement by reference.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Ventas Enters ATM Sales Agreement Amendment No. 1
Ventas said it entered into Amendment No. 1 to its ATM Sales Agreement on June 13, 2025, September 18, 2024, with BofA Securities, Inc. and other sales agents and forward sellers, and with forward purchasers.
Source · Based on the filing body and exhibits
Aggregate Gross Sales Price Available Under ATM Program $2,250,000,000
The company said that under Amendment No. 1, the aggregate gross sales price of common stock now available for issuance under the Sales Agreement is $2,250,000,000, and that this amount excludes shares sold under the Sales Agreement before Amendment No. 1 was executed.
Source · Based on the filing body and exhibits
Sales Method Under Form S-3 Registration Statement
The company said shares it issues and sells under the Sales Agreement, and shares borrowed by forward purchasers and sold, will be offered under Form S-3 (File No. 333-277185) and the prospectus supplement filed the same day.
Source · Based on the filing body and exhibits
Exhibits: Amendment No. 1 and Legal Opinion
The company said it is filing Amendment No. 1 as Exhibit 1.1 and a Davis Polk & Wardwell LLP opinion on the validity of common stock as Exhibit 5.1, and incorporating both into the registration statement by reference.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…